KCNK3-BASED GENE THERAPY OF CARDIAC ARRHYTHMIA

• 收藏
• 分享

专利权人:

UNIVERSITÄT HEIDELBERG

发明人:

Constanze SCHMIDT,Felix WIEDMANN,Hugo KATUS,Dierk THOMAS,Oliver MÜLLER

申请号：

US16754493

公开号：

US20200308582A1

申请日:

2018.10.12

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention relates to an antagonist of the Two-Pore Domain Potassium Channel (TASK-1) K2P3.1 for use in the prevention and/or treatment of cardiac arrhythmia in a subject. The invention also relates to a nucleic acid molecule usable in the prevention and/or treatment of cardiac arrhythmia in a subject. The invention further relates to a cell comprising said nucleic acid molecule. The invention further relates to a vector comprising said nucleic acid molecule.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/